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We conducted a survey including 3334 bloodstream infections (BSIs) due to E.coli
diagnosed in 2005–2014 at a stable cohort of hospitals. Marked increases in incidence
were observed for community-acquired (CA) BSIs in patients aged >75 years, CA-BSIs
of digestive origin in patients aged 60–74 years, healthcare-associated BSIs, and BSIs
associated with ESBL (extended-spectrum B-lactamase)-producing E. coli (ESBLEc).
Using MLST, we studied the genetic diversity of 412 BSI isolates recovered during the
2014 survey: 7 major sequence type complexes (STCs) were revealed in phylogenetic
group B2, 3 in group A/B1 and 2 in group D. Among the 31 ESBLEc isolates, 1/3
belonged to STC 131. We searched for possible associations between clonal groups,
clinical determinants and characteristics of BSIs: isolates from groups B2 (except STC
131) and D were susceptible to antibiotics and associated with BSIs of urinary origin
in patients <60 years. STC 131 and group A/B1 isolates were multi-drug resistant and
associated with CA-BSIs of digestive origin in patients aged 60–74 with a recent history
of antibiotic treatment. STC 131 isolates were associated with HCA-BSIs in patients with
recent/present hospitalization in a long-stay unit. We provide a unique population-based
picture of the epidemiology of E. coli BSI. The aging nature of the population led to an
increase in the number of cases caused by the B2 and D isolates generally implicated in
BSIs. In addition, the association of a trend toward increasing rates of gut colonization
with multi drug-resistant isolates revealed by the rise in the incidence of BSIs of digestive
origin caused by STC 131 and A/B1 (STCs 10, 23, and 155) isolates, and a significant
increase in the frequency of BSIs in elderly patients with recent antibiotic treatment
suggested that antibiotic use may have contributed to the growing incidence of BSI.
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Introduction
Bloodstream infections (BSIs) are among the most severe
human infections, with markedly high rates of morbidity and
mortality. E. coli is the principal agent responsible for BSI
in both patients with no recent history of healthcare (i.e.,
community-acquired, CA) (Laupland, 2013) and in patients
recently or currently managed in a healthcare institution (i.e.,
healthcare-associated, HCA). Escherichia coli is a pathogen
and a commensal organism of the mammalian intestine,
usually described as “commensal,” “intestinal pathogenic,” or
“extraintestinal pathogenic.” Intestinal pathogenic isolates cause
diarrhea, mostly by producing toxins, and by invading and
damaging the intestinal mucosa. Extraintestinal pathogenic
isolates (ExPEC) cause urinary tract infections and BSIs through
the production of toxins, adhesins, polysaccharide capsules,
siderophores, and invasins, enabling them to evade host defenses
and invade host tissues. Phylogenetic analyses have assigned E.
coli isolates to six phylogenetic groups (A, B1, B2, C, D, and
E). ExPEC strains generally belong to group B2, and, to a lesser
extent, group D, whereas commensal strains and less virulent
strains belong to group A or B1 (Tenaillon et al., 2010).
TABLE 1 | Demographic and clinical characteristics of 2209 CA-BSIs.
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 All
PATIENTS 108 187 221 213 249 231 235 231 250 284 2209
Male/female 41/67 72/115 89/132 92/121 99/150 85/146 98/137 87/144 119/131 112/172 894/1315
M/F ratio 0.6 0.6 0.7 0.8 0.7 0.6 0.7 0.6 0.9 0.6 0.7
Patient’s age (mean/median)
Male 71/73 68/71 69/74 69/74 70/76 71/74 74/76 73/76 70/76 74/78 71/75
Female 70/74 63/72 66/75 68/77 70/77 70/77 72/78 70/78 74/74 72/80 70/77
Age group < 60 23 55 56 53 51 56 38 46 49 55 466
60–74 35 55 55 52 61 50 59 59 54 60 540
≥75 50 77 110 108 137 125 138 126 147 169 1187
Death within 7 days (%) 10 (9.3) 14 (7.5) 14 (6.3) 21 (9.9) 15 (6.0) 7 (3.0) 11 (4.7) 13 (5.6) 14 (5.6) 16 (5.6) 135 (6.1)
BSI
Urinary origin (%) 67 (62.0) 125 (66.8) 132 (59.7) 122 (57.3) 156 (62.6) 121 (52.4) 141 (60.0) 135 (58.4) 141 (56.4) 165 (58.1) 1305 (59.1)
Male 18 41 41 37 41 29 46 31 46 41 371
Female 49 84 91 85 115 92 95 104 95 124 934
Age group < 60 16 39 35 32 38 35 29 33 25 41 323
60–74 21 39 37 24 36 22 35 32 28 30 304
≥75 30 47 60 66 82 64 77 70 88 94 678
Digestive origin (%) 23 (21.3) 38 (20.3) 55 (24.9) 41 (19.2) 47 (18.9) 70 (30.3) 57 (24.2) 61 (26.4) 78 (31.2) 84 (29.6) 556 (25.2)
Male 11 18 29 24 31 38 29 36 57 48 321
Age group < 60 1 4 5 3 5 9 4 5 13 9 58
60–74 5 7 8 10 5 12 10 15 17 14 103
≥75 5 7 16 11 21 17 15 16 27 25 160
Female 12 20 26 17 16 32 28 25 23 36 235
Age group < 60 2 5 4 2 4 2 3 5 1 28
60–74 2 3 5 3 3 6 5 3 7 10 47
≥75 8 12 17 12 13 22 21 19 11 25 160
Pulmonary origin 5 1 5 7 3 5 7 9 5 9 56
Other origin 4 8 8 14 13 11 12 6 14 3 93
Origin unknown 9 15 21 29 30 24 18 20 10 23 199
Various networks recently reported changes in the
epidemiological features of E. coli infections in humans,
showing an increase in the incidence of BSIs (Laupland, 2013;
Williamson et al., 2013; Lai et al., 2014). Molecular studies
showed that five major lineages (ST complexes 31, 69, 73, 95,
and 131) were responsible for most ExPEC infections in humans
and food animals (Maluta et al., 2014; Riley, 2014). Matches
between isolates recovered from food animals and clinical
isolates have suggested that the food animal reservoir may have
contributed to the observed epidemiological changes in human
infections (Manges et al., 2001; Vincent et al., 2010; Lazarus et al.,
2015).
The infection control network of the Centre region of France
annually conducts a prospective longitudinal BSI survey, to
investigate the overall incidence of BSIs in the population
and to improve our understanding of the course of these
infections. In this work, we examined regional trends in the
incidence of particular subgroups of BSIs (i.e., CA- and HCA-
BSIs, BSIs of digestive or urinary origin, and BSIs associated
with ESBL-producing isolates). The genetic characteristics of the
E. coli BSI isolates were investigated, by characterizing isolates
associated with BSI cases identified during the 2014 survey and
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searching for possible associations between clonal groups, clinical
determinants and characteristics of BSIs.
Materials and Methods
BSI Epidemiological Survey
The Centre region of France had a population of approximately
2.6 million at the time of the study (Supplementary Table
1). An annual 3-month survey of all cases of BSIs has been
conducted in this region since 2000 (van der Mee-Marquet
et al., 2004). In 2005–2014, a stable cohort of 32 hospitals
participated in this program. These institutions had a total
of 6904 short-stay beds and 3308 long-stay beds, accounting
for 81.9% of the short-stay and 59.5% of the long-stay beds
in the entire region. The survey covered 7,055,503 patient-
days (PDs). The methods and study design have been reported
elsewhere (van der Mee-Marquet et al., 2004). Briefly, BSI was
defined as a positive blood culture from a patient with clinical
or laboratory evidence of infection. The variables reported
included patient age and sex, origin of the BSI [skin (primary
cutaneous form or superinfection of a skin wound), surgical
site, lungs, urinary tract, intravascular device, intra-abdominal
or digestive tract], CA- or HCA-BSI and death within 7 days
of BSI diagnosis. The origin of the BSI was determined by the
doctor responsible for patient care, taking clinical and biological
data into account. During the 2014 survey period, incontinence,
recent history of hospitalization, living in a nursing home,
and recent antibiotic treatment were also recorded. Data were
analyzed with Epi Info version 6 software. Ethics approval for
the survey was obtained from the Réseau Alerte Investigation
Surveillance des Infections Nosocomiales (RAISIN). The study was
managed jointly with the directors of the hospitals, the doctors
responsible for patient care and the regional infection-control
team.
Microbiological Methods
Bacteriology and Antimicrobial Susceptibility Testing
During the 2005–2014 survey period, microbial identification
and antimicrobial drug susceptibility testing were performed in
the laboratories of the 32 participating centers. These laboratories
used procedures in accordance with the recommendations of
the French Antibiogram Committee and were subjected to
external quality control (van der Mee-Marquet et al., 2003,
http://www.sfm-microbiologie.org). For each case of BSI due
to E. coli, the susceptibilities to ampicillin and cefotaxime
of the corresponding isolate were reported, together with the
clinical data. All isolates showing decreased susceptibility to
second/third-generation cephalosporins were tested for ESBL
production. A reduced susceptibility to cephalosporins was
defined according to the French guidelines (http://www.sfm-
microbiologie.org). In the case of a diminished susceptibility
of the isolate (MIC > 1 mg/L) for at least one of the six
cephalosporins (cefotaxime, ceftriaxone, ceftazidime, cefepime,
cefpirome, cefixime), the production of ESBL was searched by the
double-disk synergy test.
In 2014, all E. coli isolates from BSI cases were sent to the
central laboratory for extensive study. E. coli identification was
confirmed by MALDI-TOF MS (BioMérieux, Lyon, France).
Antimicrobial drug susceptibility testing was performed by the
agar disk diffusion method (http://www.sfm-microbiologie.org),
TABLE 2 | Demographic and clinical characteristics of 1125 HCA-BSIs.
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 All
Patient days in HCIs 370,250 444,518 456,053 486,226 492,269 446,157 438,624 483,757 470,028 474,953 4,562,835
Patients 58 91 112 110 108 121 112 120 134 159 1125
Male/female 27/31 45/46 56/56 69/41 59/49 65/56 51/61 66/54 70/64 81/78 589/536
M/F ratio 0.9 1.0 1.0 1.7 1.2 1.2 0.8 1.2 1.1 1.0 1.1
Patient’s age (mean/median)
Male 74/77 67/71 69/71 74/76 73/75 67/70 68/76 72/75 72/74 71/73 74/77
Female 72/75 71/79 74/76 72/80 72/76 69/75 71/77 74/79 77/78 70/75 72/77
Age group < 60 12 18 23 24 14 24 27 20 19 32 213
60–74 18 21 36 31 36 36 37 31 37 49 332
≥75 28 52 53 55 58 61 48 69 78 78 580
Recent
Urinary catheterization (%) 18 (31.0) 23 (25.3) 26 (23.2) 29 (26.4) 41 (38.0) 33 (27.3) 26 (23.2) 40 (33.3) 34 (25.4) 56 (35.2) 326 (29.0)
Mechanical ventilation (%) 1 (1.1) 1 (0.9) 3 (2.8) 1 (0.8) 2 (1.8) 2 (1.7) 4 (2.5) 14 (1.2)
Death within 7 days (%) 5 (8.6) 9 (9.9) 10 (8.9) 16 (14.5) 13 (12.0) 18 (14.9) 10 (8.9) 12 (10.0) 17 (12.7) 13 (8.2) 123 (10.9)
BSI
Urinary origin (%) 35 (60.3) 55 (60.4) 58 (51.8) 57 (51.8) 65 (60.2) 58 (47.9) 57 (50.9) 70 (58.3) 67 (50.0) 88 (55.3) 610 (54.2)
Digestive origin (%) 10 (17.2) 10 (11.0) 22 (19.6) 20 (18.2) 14 (13.0) 22 (18.2) 14 (12.5) 20 (16.7) 31 (23.1) 26 (16.3) 189 (16.8)
Pulmonary origin 2 4 5 5 3 4 7 30
Other origin 11 11 25 20 12 26 29 18 27 22 201
Origin unknown 2 15 7 11 13 10 7 9 5 16 95
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and isolates displaying decreased susceptibility to second/third-
generation cephalosporins were tested for ESBL production.
PCR assays were used to characterize the molecular
mechanism associated with ESBL production, as described by
Brechet et al. (2014).
MLST was used to study the genetic diversity of the isolates, as
described by Wirth et al. (2006). All the allelic profiles obtained
were analyzed, sequence type (ST) and ST complex (STC)
were assigned according to the E. coli MLST database (http://
mlst.warwick.ac.uk/mlst/). STCs were defined as groups of at
least 3 STs sharing 6 alleles in pair-wise comparisons. Previous
publications and the eBURST algorithmwere used to assign STCs
to STs that were not available from the E. coli MLST database. A
neighbor-joining tree of the seven concatenated MLST genes was
also used to classify our collection of isolates. The analysis was
performed with MEGA6 software.
Data Analysis
We took fluctuations in the population of the region during the
study period into account, by expressing the incidence of CA-
BSI cases (numerator) relative to the population of the region
(denominator). The population data were obtained from the
INSEE national database (Institut National de la Statistique et
des Etudes Economiques, www.insee.fr). As our network covered
most of the hospital centers of the region, we were confident that
the participating centers were representative of the whole region.
The statistical significance of temporal trends was assessed by
Poisson or negative binomial regression for incidence rates, the
Cochran–Armitage test for proportions and Spearman’s rank
correlation analysis for continuous variables. For categorical
variables, we used Pearson’s chi-squared test to compare groups.
All analyses were two-tailed and a p < 0.05 was considered
significant. We used Stata version 10.0 software (Stata Corp.,
College Station, TX, USA) for statistical analysis.
Results
Epidemiology of E. coli BSIs over a Decade
From 2005 to 2014, the overall population of the region increased
by 2.8%. The population of elderly people aged between 60 and
74 increased by 23.4%, the very old (>74) by 16.8%, whereas the
population of people aged between 20 and 39 years decreased by
9% (Supplementary Table 1). Over this period, 3334 cases of BSI
due to E. coli were identified, 1483 in male patients and 1851 in
female patients. Most of the patients were hospitalized in short-
stay units (95.3%). CA-BSIs accounted for 2209 cases (Table 1),
whereas 1125 were attributed to HA-BSIs (Table 2).
Community-acquired BSIs
A major increase in the incidence (+156%, significant upward
trend, p < 0.001) of CA-BSI was observed (number of
cases per 100,000 inhabitants/3 months of a year), with similar
trends observed for male (+166%) and female (+149%) patients.
This global trend was almost entirely due to a significant
increase in the incidence of BSI in people >74 years old
(p < 0.001), with no major change observed in the other age
groups (Figure 1A). Consistently, the median age of the patients
increased significantly during the study period, from 73 to 78
years for men (p < 0.001), and from 74 to 80 for women
(p = 0.035) (Table 1). There was a trend toward an increase in
the incidence of BSIs of digestive (Figure 1B) or urinary origin
(Figure 1C). This trend was similar for male and female patients
FIGURE 1 | Trends in CA-BSI incidence (no. of cases/100,000 inhabitants/3 months per year) by age group (A), by origin of BSI (B and C) and for BSIs
with ESBL-producing E. coli isolates (D).
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for urinary origin (c.a. 170%), but differed significantly between
the sexes for digestive origin (male, 319%, p < 0.001; female,
171%, p = 0.002); Table 1). A major increase in the incidence of
BSIs associated with an ESBLEc was observed (+291%; p < 0.001;
Table 3 and Figure 1D), mostly in the very old (Figure 1D). Note
that the only trend toward an increase in patients <74 years
concerned BSIs of digestive origin in patients aged 60–74 years
(+177%; p = 0.001; Figure 1B). The early mortality rate did not
increase significantly during the study period.
Healthcare-associated (HA) BSIs
A 114% increase in incidence was identified for HCA-BSIs
(number of cases per 1000 PDs, Table 2, Figure 2A). This global
trend was due to BSIs in patients >74 years old, but also,
to a lesser extent, patients aged 60–74 years (Figure 2B). By
contrast with CA-BSI cases, the median age of patients with
HCA-BSI did not change during the study period (Table 2). The
observed increases were similar for male and female patients,
and mostly concerned BSIs of urinary origin (+96%). The
increasing incidence of BSI cases with a urinary origin was
similar for patients with and without a recent history of urinary
catheterization (Figure 2C). A large increase was observed in the
incidence of BSIs associated with ESBLEc (0.003/1000 PDs in
2005 and 0.042 in 2014; p < 0.001) (Table 3 and Figure 2D). As
for CA-BSI, the early mortality rate did not increase significantly
during the study period.
Molecular Characterization of E. Coli Isolates
In total, 412 (93.0%) isolates were available formolecular analysis,
from the 443 BSIs diagnosed in 2014. The clinical determinants
and characteristics of these 412 BSIs are presented in Table 4.
Genetic Diversity of Isolates
MLST recovered 102 STs from the 412 isolates. The neighbor-
joining tree obtained from the concatenated sequences revealed
12 major STCs containing 321 isolates (77.9%) (Figure 3). Seven
of them (STCs 73, 95, 131, 14, 12, 141, and 92) belonged to group
B2 and two to group D (STC 69 and 31). The three remaining
major clones (STCs 23, 10, and 155) belonged to groups A and B1.
The remaining 91 isolates belonged to unique STs or were placed
in minor groups (Table 4). Overall, 55.6, 13.6, and 25.7% of the
isolates studied belonged to groups B2, D, and A/B1, respectively.
Antimicrobial Drug Susceptibility
One hundred ninety-nine (48.3%) isolates were susceptible to
all antibiotics tested. Seventy-nine were resistant to amoxicillin
only (19.2%) and 47 (11.4%) were resistant to amoxicillin and
trimethoprim/sulfamethozaxole (TMP/SXZ); 33 were resistant to
cefotaxime (8.0%), all but two being ESBLEc (7.5%) (Table 4).
In all but one case, the ESBL belonged to the CTX-M family.
Most of the 30 CTX-M ESBLs were of types M15 (43.3%) and
M1 (23.3%); 98 isolates were resistant to TMP/SXZ (23.8%), 69 to
fluoroquinolone (16.7%) and 39 to tobramycin and gentamicin
(9.5%). ESBLEc were mostly multidrug-resistant, with 74.2%
resistant to fluoroquinolone, 64.5% to TMP/SXZ and 51.6%
to tobramycin and gentamicin. None of the 412 isolates was
resistant to imipenem or ertapenem.
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FIGURE 2 | Trends in HCA-BSI incidence (no. of cases/1000 PDs and/100,000 inhabitants/3 months per year) by age group (A and B), for BSIs with a
urinary origin in patients with and without recent catheterization (C) and for BSIs with ESBL-producing E. coli isolates (D).
Genotypes and Clinical Determinants
STC 131 isolates were associated with BSIs in patients
hospitalized in a RC/LSU (p < 0.001), or recently hospitalized
in a rehabilitation care-or long-stay unit (RC/LCU) (p = 0.007),
and patients with recent urinary catheterization (p = 0.002) or
recent antibiotic treatment (p < 0.006). Two characteristics were
common to A/B1 and STC 131 isolates: the isolates from these
groups were associated with BSIs in patients aged 60–74 years
(p < 0.001) or recently treated with cephalosporin (p = 0.011).
Genotypes and the Presumed Origin of the BSI
A/B1 and STC 131 isolates were associated with CA-BSIs of
digestive origin (p < 0.001); by contrast, B2 (except STC 131) and
D isolates were associated with CA-BSIs with a urinary source
(p = 0.005). STC 131 isolates were associated with HCA-BSIs
(p = 0.047).
Genotypes and the Antibiotic Susceptibility of E. coli
Isolates
STC 131 isolates were associated with resistance to
fluoroquinolones (p < 0.001). A/B1 and STC 131 isolates were
associated with resistance to amoxicillin and fluoroquinolones
(p < 0.001) and resistance to cefotaxime (p = 0.022). ESBL
production was associated with isolates of STCs 10, 155, and
131 (p < 0.001). CTX-M15 ESBLs were associated with STC131
(p = 0.051) and CTX-M1 with STC 155 (p = 0.045). B2
isolates (except STC 131) were associated with susceptibility to
all antibiotics tested (p < 0.001), and D isolates were associated
with resistance to amoxicillin and TMP/SMZ (p = 0.016).
Clinical Determinants, the Characteristics of the BSIs
and ESBLEc
ESBLEc-BSIs were associated with healthcare (p = 0.004),
hospitalization in a LSU (p = 0.018), and recent antibiotic
treatment (p = 0.002). ESBLEc were associated with resistance
to fluoroquinolones, SXT/TMP and tobramycin/gentamicin (p <
0.001). The clinical determinants and characteristics of ESBLEc-
BSIs were similar for all clonal groups other than STC 131, for
which infection was associated with hospitalization in a long-stay
unit (p = 0.042). For STC 131-BSIs, clinical determinants and
the characteristics of the infection were similar for ESBLEc and
non-ESBLEc.
Discussion
This longitudinal prospective BSI survey provides a unique
contemporary population-based picture of the epidemiology of
E. coli BSI in a large part of France, and highlights two main
factors that may have contributed to the growing incidence of
BSIs due to E. coli: the aging of the population, and antibiotic use.
The increase in the incidence of BSIs due to E. coli observed
in our population during the study period differed between age
groups. The increase almost entirely concerned the very old
(>74 years). Susceptibility to infectious diseases in the elderly
is increased by a combination of factors, including immune
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TABLE 4 | Clinical data, characteristics of 412 BSIs and molecular characteristics of the related E. coli isolates.
B2 D A/B1 Others All
ST131 Other B2
PATIENTS 25 204 56 106 21 412
Sex (male/female) (ratio) 14/11 (1.3) 91/113 (0.8) 19/37(0.5) 48/58 (0.8) 14/7 (2.0) 186/226 (0.8)
Age mean/median 70/71 72/80 73/80 75/78 73/76 73/78
Age group < 60 (%) 6 (24.0) 44 (21.6) 13 (23.2) 9 (8.5) 4 (19.0) 76 (18.5)
60–74 (%) 8 (32.0) 40 (19.6) 9 (16.1) 38 (35.8) 4 (19.0) 99 (24.0)
≥75 (%) 11 (44.0) 120 (58.8) 34 (60.7) 59 (55.7) 13 (61.9) 237 (57.5)
Incontinence U/F 8/5 43/23 11/7 16/4 2/1 80/40
Recent
Urinary catheterization (%)
9 (36.0) 27 (13.2) 6 (10.7) 8 (7.5) 2 (9.5) 52 (12.6)
Stay in RC/LSU (%) 5 (20.0) 9 (4.4) 2 (3.6) 5 (4.7) 1 (4.8) 22 (5.3)
Living in nursing home (%) 4 (16.0) 18 (8.8) 6 (10.7) 4 (3.8) 2 (9.5) 34 (8.2)
Antibiotic treatment (%) 13 (52.0) 41 (20.1) 16 (28.6) 38 (35.8) 7 (33.3) 115 (27.9)
Fluoroquinolone 2 (8.0) 3 (1.5) 3 (5.4) 4 (3.8) 1 (4.8) 13 (3.2)
Cephalosporin 3 (12.0) 11 (5.4) 5 (8.9) 14 (13.2) 33 (8.0)
Death within 7 days (%) 17 (8.3) 4 (7.1) 7 (6.6) 28 (6.8)
BSI
CA/HCA (ratio) 11/14 (0.8) 133/71 (1.9) 34/22 (1.5) 68/38 (1.8) 12/9 (1.3) 258/154 (1.7)
Urinary source (%) 17 (68.0) 134 (65.7) 34 (60.7) 45 (42.4) 7 (33.3) 237 (57.5)
CA-BSI (%) 5 (45.4) 92 (69.2) 20 (58.8) 31 (45.6) 5 (23.8) 153 (59.3)
HCA-BSI (%) 12 (85.7) 42 (59.1) 14 (63.6) 14 (36.8) 2 (9.5) 84 (54.5)
Digestive source (%) 7 (28.0) 30 (14.7) 13 (23.2) 39 (36.8) 12 (57.1) 101 (25.5)
CA-BSI (%) 6 (54.5) 22 (16.5) 9 (26.5) 29 (42.6) 2 (9.5) 74 (28.7)
HCA-BSI (%) 1 (7.1) 8 (11.0) 4 (18.2) 10 (26.3) 1 (4.8) 27 (17.5)
Other sources/not known 1/0 18/22 5/4 11/11 0/2 35/39
E. COLI ISOLATES
Antibiotic susceptibility pattern
Susceptible to antibiotic tested (%) 3 (12.0) 140 (68.6) 13 (23.2) 32 (30.2) 11 (52.4) 199 (48.3)
FQ R 1 1 2 4
SXT/TMP R 2 2
FQ + SXT/TMP R 1 2 3
SXT/TMP + To/Gn R 1 1
AMX R (%) 2 (8.0) 41 (20.1) 18 (32.1) 18 (17.0) 79 (19.2)
AMX + FQ R (%) 2 (8.0) 2 (1.0) 1 (1.8) 9 (8.5) 14 (3.4)
AMX + SXT/TMP R (%) 16 (7.8) 11 (19.6) 14 (13.2) 6 (28.6) 47 (11.4)
AMX + To/Gn R 2 2
AMX + FQ + SXT/TMP R 3 4 1 (4.8) 8
AMX + FQ + To/Gn R 3 3
AMX + SXT/TMP + To/Gn R 1 2 1 4
AMX + FQ + SXT/TMP + To/Gn R (%) 3 (12.0) 1 (1.8) 8 (7.5) 12 (2.9)
AMX + FQ + SXT/TMP R (ESBL+) 1 1
CFX R (ESBL+) 1 1 2
CFX + FQ R (ESBL+) 2 1 2 5
CFX + SXT/TMP R (ESBL+) 1 3 4
CFX + SXT/TMP + To/Gn R (ESBL+) 1 1 2
CFX + FQ + SXT/TMP R (ESBL+) 3 3
CFX + FQ + To/Gn R (ESBL+) (%) 4 (16.0) 4 (1.0)
CFX + FQ + SXT/TMP + To/Gn R (ESBL+) 3 (12.0) 1 (0.5) 1 (1.8) 4 (3.8) 1 (4.8) 10 (2.4)
CFX R (no ESBL) 1 1
CFX + FQ + To/Gn R (no ESBL) 1 1
CFX + FQ + SXT/TMP R (no ESBL) 1 1
(Continued)
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TABLE 4 | Continued
B2 D A/B1 Others All
ST131 Other B2
Antibiotic resistance
CFX (%) 10 (40.0) 4 (2.0) 4 (7.1) 14 (13.2) 1 (4.8) 33 (8.0)
FQ (%) 18 (72.0) 5 (2.4) 8 (14.3) 34 (32.1) 4 (19.0) 69 (16.7)
SXT/TMP (%) 9 (36.0) 18 (8.8) 20 (35.7) 41 (38.7) 10 (47.6) 98 (23.8)
ESBL production (%) 11 (44.0) 4 (2.0) 3 (5.4) 12 (11.3) 1 (4.8) 31 (7.5)
senescence, denutrition, changes in skin and mucosal barrier
functions, degenerative changes in bone and cartilage, a decrease
in respiratory capacity and common comorbid conditions. BSI
is a leading cause of morbidity and mortality in the geriatric
population, and its frequency is higher in the elderly than in
other age groups (Uslan et al., 2007). The subpopulation of
individuals >74 years old increased over the study period in this
region, consistent with the increase in the number of BSI cases.
However, the range of increases in BSI incidence was much
larger than that for the very old subpopulation itself, suggesting
a contribution of factors other than aging to the increase in BSI
incidence. Regarding CA-BSIs only, an increase in BSI incidence
was observed in patients aged 60–74 years, particularly for BSIs
of digestive origin. The intestinal tract being the immediate
reservoir of the ExPEC, these findings suggest that E. coli
colonizing the gut may be increasingly able to cause BSI in the
elderly.
CA- and HCA-BSIs, despite displaying an increase in
incidence, did not lead to an increase in early mortality. This
finding suggests that an increase in the virulence of the isolates
involved in BSIs is unlikely. Nevertheless, this study had several
limitations, including the lack of investigation of possible changes
in therapeutic management by the physicians during the study,
and the impossibility of analyzing BSIs from critically ill and
moderately ill patients separately. Therefore, further studies
should be conducted to clarify this point.
Consistent with recent reports for E. coli BSI isolates (Adams-
Sapper et al., 2013; Burdet et al., 2014; Horner et al., 2014), most
of the 412 studied isolates belonged to the major ExPEC, with a
predominance of the B2 and D groups (STC 73, 95, 131 and 69).
However, we found a lower proportion of BSIs due to group B2
and a higher proportion due to groupA/B1 than in these previous
reports (Jaureguy et al., 2008; Bert et al., 2010). We investigated
BSI isolates from 2014, whereas previous reports investigated
earlier isolates. Our results may indicate an increasing and recent
implication of the A/B1 group in human BSIs.
Three major groups were defined on the basis of the
characteristics of isolates and the clinical determinants of BSIs.
First, isolates from groups B2 (except STC 131) and D were
mostly highly susceptible to antibiotics and associated with BSIs
of urinary origin in patients <60 years old, highlighting their
well-recognized virulence. Second, STC 131, which included
many isolates resistant to fluoroquinolones, and TMP/SXZ;
they were ESBL-producers, and associated with HCA-BSIs of
urinary origin in patients with recent/present hospitalization
in long-stay units, and with CA-BSI of digestive origin in
patients aged 60–74 years recently treated with antibiotics.
The third group consisted of A/B1 isolates, usually considered
commensal, with many features in common with STC 131
isolates regarding CA-BSIs. These isolates were frequently
resistant to fluoroquinolones, TMP/SXZ and produced ESBL,
and they were associated with CA-BSI cases of digestive origin
in patients aged 60–74 years recently treated with antibiotics,
particularly cephalosporins.
The A/B1 isolates of STCs 23, 10, and 155 have been shown
to colonize food animals, to infect animals and humans (Manges
et al., 2001; Huijbers et al., 2014; Maluta et al., 2014; Lazarus
et al., 2015), and to be associated with perfect matches between
isolates recovered from humans and chickens (Cortés et al., 2010;
Kluytmans et al., 2013); they are thus considered to be associated
with a zoonotic risk (Lazarus et al., 2015). Our study showed
that BSI cases of digestive origin were mostly caused by isolates
from these clonal complexes and STC 131. The number of BSI
cases of digestive origin due to E. coli increased over the study
period. Our results suggest that E. coli from the these clonal
complexes probably colonize the intestines more frequently
and/or successfully, thereby contributing to the growing number
of BSIs observed over the study period.
The significant association of BSI with STC 131 and A/B1
isolates and recent antibiotic treatment suggested that prior
exposure of the gut to antibiotics might have led to long-lasting,
strong colonization by these isolates, this process being favored
by the high frequency of antibiotic resistance genes in their
genomes. Recent reports concerning antibiotic consumption
(Bernier et al., 2014; http://www.cclin-arlin.fr, 2014)1 have
described an increase in the use of antibiotics by the elderly over
the study period. As data from our region were included in these
studies, these trends toward an increase may apply to our region.
Thus, our findings suggest that the increasing incidence of BSIs,
often of digestive origin and mostly linked to antibiotic-resistant
STC 131 and A/B1 isolates may at least partly result from the
increasing use of antibiotics by inpatients and outpatients in our
region during the study period.
1Institut de Veille Sanitaire and Agence Nationale de Sécurité
du Médicament et des Produits de santé. Consommation
d’antibiotiques et résistance aux antibiotiques en France: nécessité
d’une mobilisation determinée et durable. Available online at:
http://www.cclin-arlin.fr/Campagnes/Antibiotiques/PLAQ_DMI_RATB-Ansm_;
BAT_14112014.pdf
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FIGURE 3 | Neighbor-joining tree obtained from the concatenated sequences of the 7 MLST loci of E. coli isolates from BSI in 2014. The 12 major ST
complexes (and their respective phylogroups) are placed on the tree.
Our last key finding was related to the large increase in the
frequency of ESBLEc-BSIs. Prior antibiotic treatment was the
only risk factor identified for these infections. We were unable to
identify any characteristic linked to clonal group, other than for
the CTX-M-15-ST131 clonal group, which was significantlymore
frequently identified in patients hospitalized in long-stay units.
The key position of this lineage, probably due to its high capacity
for intestine colonization and urinary tract infections (Vimont
et al., 2012), highlights the need for infection control measures to
limit the spread of this clone in units caring for elderly patients.
Conclusion
This study has incidence data spanning 2005–2014 and provides
insight into changes in the epidemiological features of BSIs due
to E. coli. Nevertheless, molecular data were only obtained for the
isolates recovered in 2014. Further studies should be performed
in different geographic areas and with the incorporation of more
clinical data, to improve our understanding of the dynamics of
the increase in E. coli BSIs in the elderly population. Molecular
studies should investigate the genetic factors associated with the
ability of the group A/B1 isolates to cause increasing numbers
of invasive infections. In addition, investigations are required to
determine whether these antibiotic-resistant isolates colonizing
the human gut originate from contaminated food products.
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